See every side of every news story
Published loading...Updated

MaaT Pharma advancing next frontier biotherapeutics with microbiome-driven therapies - BioTuesdays

Summary by biotuesdays.com
By Melane Sampson Hervé Affagard, Co-founder and CEO MaaT Pharma (EURONEXT:MAAT) is at the forefront of developing the world’s first full-ecosystem approach to restoring microbiome symbiosis in oncology, improving cancer patient survival through innovative, fecal-derived therapies designed to modulate the immune system and restore gut balance. “We founded MaaT Pharma with the mission of extending the lives of cancer patients. To achieve this, w…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

biotuesdays.com broke the news in on Tuesday, April 1, 2025.
Sources are mostly out of (0)

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.